Drug Shortage Report for IZBA
Report ID | 170482 |
Drug Identification Number | 02457997 |
Brand name | IZBA |
Common or Proper name | IZBA 0.003% SOLN. |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TRAVOPROST |
Strength(s) | 0.003% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01EE |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-10-07 |
Actual start date | 2022-10-18 |
Estimated end date | 2022-12-09 |
Actual end date | 2022-12-12 |
Shortage status | Resolved |
Updated date | 2023-01-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-01-06 | French | Compare |
v11 | 2023-01-06 | English | Compare |
v10 | 2022-11-15 | French | Compare |
v9 | 2022-11-15 | English | Compare |
v8 | 2022-10-21 | French | Compare |
v7 | 2022-10-21 | English | Compare |
v6 | 2022-10-19 | English | Compare |
v5 | 2022-10-18 | French | Compare |
v4 | 2022-10-18 | English | Compare |
v3 | 2022-10-08 | English | Compare |
v2 | 2022-09-29 | French | Compare |
v1 | 2022-09-29 | English | Compare |
Showing 1 to 12 of 12